Aehr Test Systems (AEHR) EBIT (2010 - 2026)

Aehr Test Systems (AEHR) has reported EBIT for 16 consecutive years, with -$1.2 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, EBIT rose 62.36% year-over-year to -$1.2 million; the trailing twelve-month figure through May 2026 stood at -$14.1 million (down 149.23% YoY), and the FY2026 full-year result was -$14.1 million, down 149.23% from the prior year.
• EBIT grew to -$1.2 million in Q2 2026 per AEHR's latest filing, from -$4.2 million in the prior quarter.
• Across five years, EBIT topped out at $5.8 million in Q2 2022 and bottomed at -$4.6 million in Q4 2025.
• Historically, EBIT has averaged $650166.7 across 5 years, with a median of $308500.0 in 2022.
• The sharpest annual moves came in 2022 and 2025: EBIT soared 868.39% in 2022, then slumped 2657.23% in 2025.
• Over 5 years, EBIT stood at $3.5 million in 2022, then jumped by 56.9% to $5.5 million in 2023, then sank by 127.67% to -$1.5 million in 2024, then slumped by 207.2% to -$4.6 million in 2025, then soared by 74.05% to -$1.2 million in 2026.
• According to Business Quant data, EBIT over the past three periods registered -$1.2 million, -$4.2 million, and -$4.6 million for Q2 2026, Q1 2026, and Q4 2025 respectively.